Lisa Waddell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lisa Waddell has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Ian Young
School of Occupational and Public Health, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada
17 shared publications Judy Greig
National Microbiology Laboratory, Public Health Agency of Canada, 370 Speedvale Ave W., Guelph, ON N1H 7M7, Canada
14 shared publicationsAndrijana Rajić
Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, N1G 2W1, Canada
11 shared publicationsScott A. McEwen
Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, Ontario, N1G 2W1, Canada
10 shared publicationsA. Rajić
Food Safety and Quality, Agriculture and Consumer Protection Department, Food and Agriculture Organization, Rome, Italy
9 shared publicationsBarbara J. Wilhelm
Big Sky Health Analytics, PO Box 3339, Vermilion, Alberta T9X 2B3, Canada
6 shared publications
Latest Publications
- Open Access
- 21 October 2025
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 3 (6)
Enhancing Evidence Synthesis Efficiency: Leveraging Large Language Models and Agentic Workflows for Optimized Literature Screening
Background: Public health events of international concern highlight the need for up‐to‐date evidence curated using sustainable processes that are accessible. In development of the Global Repository of Epidemiological Parameters (grEPI) we explore the performance of an agentic‐AI assisted pipeline (GREP‐Agent) for screening evidence which capitalizes on recent advancements in large language models (LLMs). Methods: In this study, the performance of the GREP‐Agent was evaluated on a data set of 2000 citations from a systematic review on measles using four LLMs (GPT4o, GPT4o‐mini, Llama3.1, and Phi4). The GREP‐Agent framework integrates multiple LLMs and human feedback to fine‐tune its performance, optimize workload reduction and accuracy in screening research articles. The impact on performance of each part of this Agentic‐AI system is presented and measured by accuracy, precision, recall, and F1‐score metrics. Results: The results show how each phase of the GREP‐Agent system incrementally improves accuracy regardless of the LLM. We found that GREP‐Agent was able to increase sensitivity across a broad range of open source and proprietary LLMs to 84.2%–88.9% after fine‐tuning and to 86.4%–95.3% by varying workload reduction strategies. Performance was significantly impacted by the clarity of the screening questions and setting thresholds for optimized workload reduction strategies. Conclusions: The GREP‐Agent shows promise in improving the efficiency and effectiveness of evidence synthesis in dynamic public health contexts. Further development and refinement of adaptable human‐in‐the‐loop AI systems for screening literature are essential to support future public health response activities, while maintaining a human‐centric approach.
- 21 October 2025
- Published by Wiley in Cochrane Evidence Synthesis and Methods
- Vol. 3 (6)
Open AccessEnhancing Evidence Synthesis Efficiency: Leveraging Large Language Models and Agentic Workflows for Optimized Literature Screening
Background: Public health events of international concern highlight the need for up‐to‐date evidence curated using sustainable processes that are accessible. In development of the Global Repository of Epidemiological Parameters (grEPI) we explore the performance of an agentic‐AI assisted pipeline (GREP‐Agent) for screening evidence which capitalizes on recent advancements in large language models (LLMs). Methods: In this study, the performance of the GREP‐Agent was evaluated on a data set of 2000 citations from a systematic review on measles using four LLMs (GPT4o, GPT4o‐mini, Llama3.1, and Phi4). The GREP‐Agent framework integrates multiple LLMs and human feedback to fine‐tune its performance, optimize workload reduction and accuracy in screening research articles. The impact on performance of each part of this Agentic‐AI system is presented and measured by accuracy, precision, recall, and F1‐score metrics. Results: The results show how each phase of the GREP‐Agent system incrementally improves accuracy regardless of the LLM. We found that GREP‐Agent was able to increase sensitivity across a broad range of open source and proprietary LLMs to 84.2%–88.9% after fine‐tuning and to 86.4%–95.3% by varying workload reduction strategies. Performance was significantly impacted by the clarity of the screening questions and setting thresholds for optimized workload reduction strategies. Conclusions: The GREP‐Agent shows promise in improving the efficiency and effectiveness of evidence synthesis in dynamic public health contexts. Further development and refinement of adaptable human‐in‐the‐loop AI systems for screening literature are essential to support future public health response activities, while maintaining a human‐centric approach.
- Top Cited PapersOpen Access
- 1 March 2025
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 45 (3) , 112-138
Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence
Introduction We investigated the prevalence of new or persistent manifestations experienced by COVID-19 survivors at 3 or more months after their initial infection, collectively known as post-COVID-19 condition (PCC). Methods We searched four electronic databases and major grey literature resources for prospective studies, systematic reviews, authoritative reports and population surveys. A random-effects meta-analysis pooled the prevalence data of 22 symptoms and outcomes. The GRADE approach was used to assess the certainty of evidence. PROSPERO CRD42021231476. Results Of 20 731 identified references, 194 met our inclusion criteria. These studies followed 483 531 individuals with confirmed COVID-19 diagnosis over periods of up to 2 years. Most focused on adults, nearly two-thirds were conducted in Europe and 63% were of high or moderate quality. The supplementary search identified 17 systematic reviews, five authoritative reports and four population surveys that reported on PCC prevalence. Our analysis revealed that more than half of COVID-19 survivors experienced one or more symptoms more than a year after their initial infection. The most common symptoms were fatiguedyspneamemory, sleep or concentration disturbances; depressionand pain. Limitation in returning to work was the most common outcome. Prevalence tended to be higher among females, individuals hospitalized during their initial infection and those who experienced severe COVID-19 illness. Conclusion PCC presents a significant health burden, affecting some groups more than others. This information will help inform health care system policies and services for people living with PCC and those caring for them.
- 1 March 2025
- Published by Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada in Health Promotion and Chronic Disease Prevention in Canada
- Vol. 45 (3) , 112-138
Top Cited PapersOpen AccessGlobal prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence
Introduction We investigated the prevalence of new or persistent manifestations experienced by COVID-19 survivors at 3 or more months after their initial infection, collectively known as post-COVID-19 condition (PCC). Methods We searched four electronic databases and major grey literature resources for prospective studies, systematic reviews, authoritative reports and population surveys. A random-effects meta-analysis pooled the prevalence data of 22 symptoms and outcomes. The GRADE approach was used to assess the certainty of evidence. PROSPERO CRD42021231476. Results Of 20 731 identified references, 194 met our inclusion criteria. These studies followed 483 531 individuals with confirmed COVID-19 diagnosis over periods of up to 2 years. Most focused on adults, nearly two-thirds were conducted in Europe and 63% were of high or moderate quality. The supplementary search identified 17 systematic reviews, five authoritative reports and four population surveys that reported on PCC prevalence. Our analysis revealed that more than half of COVID-19 survivors experienced one or more symptoms more than a year after their initial infection. The most common symptoms were fatiguedyspneamemory, sleep or concentration disturbances; depressionand pain. Limitation in returning to work was the most common outcome. Prevalence tended to be higher among females, individuals hospitalized during their initial infection and those who experienced severe COVID-19 illness. Conclusion PCC presents a significant health burden, affecting some groups more than others. This information will help inform health care system policies and services for people living with PCC and those caring for them.
- Open Access
- 16 January 2024
- Published by IWA Publishing in Journal of Water and Health
- Vol. 22 (2) , 436-449
A scoping review of human pathogens detected in untreated human wastewater and sludge
Wastewater monitoring is an approach to identify the presence or abundance of pathogens within a population. The objective of this scoping review (ScR) was to identify and characterize research on human pathogens and antimicrobial resistance detected in untreated human wastewater and sludge. A search was conducted up to March 2023 and standard ScR methodology was followed. This ScR included 1,722 articles, of which 56.5% were published after the emergence of COVID-19. Viruses and bacteria were commonly investigated, while research on protozoa, helminths, and fungi was infrequent. Articles prior to 2019 were dominated by research on pathogens transmitted through fecal–oral or waterborne pathways, whereas more recent articles have explored the detection of pathogens transmitted through other pathways such as respiratory and vector-borne. There was variation in sampling, samples, and sample processing across studies. The current evidence suggests that wastewater monitoring could be applied to a range of pathogens as a public health tool to detect an emerging pathogen and understand the burden and spread of disease to inform decision-making. Further development and refinement of the methods to identify and interpret wastewater signals for different prioritized pathogens are needed to develop standards on when, why, and how to monitor effectively.
- 16 January 2024
- Published by IWA Publishing in Journal of Water and Health
- Vol. 22 (2) , 436-449
Open AccessA scoping review of human pathogens detected in untreated human wastewater and sludge
Wastewater monitoring is an approach to identify the presence or abundance of pathogens within a population. The objective of this scoping review (ScR) was to identify and characterize research on human pathogens and antimicrobial resistance detected in untreated human wastewater and sludge. A search was conducted up to March 2023 and standard ScR methodology was followed. This ScR included 1,722 articles, of which 56.5% were published after the emergence of COVID-19. Viruses and bacteria were commonly investigated, while research on protozoa, helminths, and fungi was infrequent. Articles prior to 2019 were dominated by research on pathogens transmitted through fecal–oral or waterborne pathways, whereas more recent articles have explored the detection of pathogens transmitted through other pathways such as respiratory and vector-borne. There was variation in sampling, samples, and sample processing across studies. The current evidence suggests that wastewater monitoring could be applied to a range of pathogens as a public health tool to detect an emerging pathogen and understand the burden and spread of disease to inform decision-making. Further development and refinement of the methods to identify and interpret wastewater signals for different prioritized pathogens are needed to develop standards on when, why, and how to monitor effectively.
- Open Access
- 3 August 2021
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 149, e182
The quality of systematic reviews and other synthesis in the time of COVID-19
COVID-19 research has been produced at an unprecedented rate and managing what is currently known is in part being accomplished through synthesis research. Here we evaluated how the need to rapidly produce syntheses has impacted the quality of the synthesis research. Thus, we sought to identify, evaluate and map the synthesis research on COVID-19 published up to 10 July 2020. A COVID-19 literature database was created using pre-specified COVID-19 search algorithms carried out in eight databases. We identified 863 citations considered to be synthesis research for evaluation in this project. Four-hundred and thirty-nine reviews were fully assessed with A MeaSurement Tool to Assess systematic Reviews (AMSTAR-2) and rated as very low-quality (n = 145), low-quality (n = 80), medium-quality (n = 208) and high-quality (n = 151). The quality of these reviews fell short of what is expected for synthesis research with key domains being left out of the typical methodology. The increase in risk of bias due to non-adherence to systematic review methodology is unknown and prevents the reader from assessing the validity of the review. The responsibility to assure the quality is held by both producers and publishers of synthesis research and our findings indicate there is a need to equip readers with the expertise to evaluate the review conduct before using it for decision-making purposes.
- 3 August 2021
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 149, e182
Open AccessThe quality of systematic reviews and other synthesis in the time of COVID-19
COVID-19 research has been produced at an unprecedented rate and managing what is currently known is in part being accomplished through synthesis research. Here we evaluated how the need to rapidly produce syntheses has impacted the quality of the synthesis research. Thus, we sought to identify, evaluate and map the synthesis research on COVID-19 published up to 10 July 2020. A COVID-19 literature database was created using pre-specified COVID-19 search algorithms carried out in eight databases. We identified 863 citations considered to be synthesis research for evaluation in this project. Four-hundred and thirty-nine reviews were fully assessed with A MeaSurement Tool to Assess systematic Reviews (AMSTAR-2) and rated as very low-quality (n = 145), low-quality (n = 80), medium-quality (n = 208) and high-quality (n = 151). The quality of these reviews fell short of what is expected for synthesis research with key domains being left out of the typical methodology. The increase in risk of bias due to non-adherence to systematic review methodology is unknown and prevents the reader from assessing the validity of the review. The responsibility to assure the quality is held by both producers and publishers of synthesis research and our findings indicate there is a need to equip readers with the expertise to evaluate the review conduct before using it for decision-making purposes.
- Open Access
- 8 July 2021
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Relevé des maladies transmissibles au Canada
- Vol. 47 (7/8) , 336-347
Caractéristiques épidémiologiques et cliniques du syndrome inflammatoire multisystémique chez les adultes : un examen rapide
Le syndrome inflammatoire multisystémique de l’enfant (MIS-C) est l’une des principales répercussions de la maladie à coronavirus 2019 (COVID-19) qui a été décrite dans la littérature depuis le début de la pandémie. Bien que le MIS-C concerne les enfants, des cas ayant des caractéristiques cliniques semblables ont récemment été décrits chez les adultes. Une description des caractéristiques épidémiologiques et cliniques du syndrome inflammatoire multisystémique de l’adulte (MIS-A) est un point de départ pour une meilleure connaissance et compréhension de cette maladie émergente. Nous avons recensé neuf cas de MIS-A dans la littérature, cinq aux États-Unis, deux en France et deux au Royaume-Uni. Les descriptions de cas ont révélé des similitudes dans les caractéristiques cliniques, y compris l’occurrence au cours de la phase post-aiguë de la maladie, la fièvre, les symptômes digestifs, des atteintes cardiaques et des marqueurs inflammatoires élevés. Tous les patients ont été hospitalisés, trois ont dû être admis à l’unité de soins intensifs et un est décédé. Les traitements les plus courants étaient l’immunoglobuline intraveineuse, la prednisolone et l’aspirine. Ces résultats suggèrent que le MIS-A est une grave complication de la COVID-19 qui peut entraîner la mort. D’autres études visant à améliorer notre compréhension de la pathogenèse du MIS-A, qui contribueront à améliorer les décisions de traitement et à prévenir les séquelles ou la mort.
- 8 July 2021
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Relevé des maladies transmissibles au Canada
- Vol. 47 (7/8) , 336-347
Open AccessCaractéristiques épidémiologiques et cliniques du syndrome inflammatoire multisystémique chez les adultes : un examen rapide
Le syndrome inflammatoire multisystémique de l’enfant (MIS-C) est l’une des principales répercussions de la maladie à coronavirus 2019 (COVID-19) qui a été décrite dans la littérature depuis le début de la pandémie. Bien que le MIS-C concerne les enfants, des cas ayant des caractéristiques cliniques semblables ont récemment été décrits chez les adultes. Une description des caractéristiques épidémiologiques et cliniques du syndrome inflammatoire multisystémique de l’adulte (MIS-A) est un point de départ pour une meilleure connaissance et compréhension de cette maladie émergente. Nous avons recensé neuf cas de MIS-A dans la littérature, cinq aux États-Unis, deux en France et deux au Royaume-Uni. Les descriptions de cas ont révélé des similitudes dans les caractéristiques cliniques, y compris l’occurrence au cours de la phase post-aiguë de la maladie, la fièvre, les symptômes digestifs, des atteintes cardiaques et des marqueurs inflammatoires élevés. Tous les patients ont été hospitalisés, trois ont dû être admis à l’unité de soins intensifs et un est décédé. Les traitements les plus courants étaient l’immunoglobuline intraveineuse, la prednisolone et l’aspirine. Ces résultats suggèrent que le MIS-A est une grave complication de la COVID-19 qui peut entraîner la mort. D’autres études visant à améliorer notre compréhension de la pathogenèse du MIS-A, qui contribueront à améliorer les décisions de traitement et à prévenir les séquelles ou la mort.
- 1 February 2020
- Published by Elsevier in Food Research International
- Vol. 128, 108711
A systematic review and meta-regression of single group, pre-post studies evaluating food safety education and training interventions for food handlers
- 1 February 2020
- Published by Elsevier in Food Research International
- Vol. 128, 108711
A systematic review and meta-regression of single group, pre-post studies evaluating food safety education and training interventions for food handlers
- Open Access
- 27 September 2019
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, e280
Methods for generating hypotheses in human enteric illness outbreak investigations: a scoping review of the evidence
Enteric illness outbreaks are complex events, therefore, outbreak investigators use many different hypothesis generation methods depending on the situation. This scoping review was conducted to describe methods used to generate a hypothesis during enteric illness outbreak investigations. The search included five databases and grey literature for articles published between 1 January 2000 and 2 May 2015. Relevance screening and article characterisation were conducted by two independent reviewers using pretested forms. There were 903 outbreaks that described hypothesis generation methods and 33 papers which focused on the evaluation of hypothesis generation methods. Common hypothesis generation methods described are analytic studies (64.8%), descriptive epidemiology (33.7%), food or environmental sampling (32.8%) and facility inspections (27.9%). The least common methods included the use of a single interviewer (0.4%) and investigation of outliers (0.4%). Most studies reported using two or more methods to generate hypotheses (81.2%), with 29.2% of studies reporting using four or more. The use of multiple different hypothesis generation methods both within and between outbreaks highlights the complexity of enteric illness outbreak investigations. Future research should examine the effectiveness of each method and the contexts for which each is most effective in efficiently leading to source identification.
- 27 September 2019
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, e280
Open AccessMethods for generating hypotheses in human enteric illness outbreak investigations: a scoping review of the evidence
Enteric illness outbreaks are complex events, therefore, outbreak investigators use many different hypothesis generation methods depending on the situation. This scoping review was conducted to describe methods used to generate a hypothesis during enteric illness outbreak investigations. The search included five databases and grey literature for articles published between 1 January 2000 and 2 May 2015. Relevance screening and article characterisation were conducted by two independent reviewers using pretested forms. There were 903 outbreaks that described hypothesis generation methods and 33 papers which focused on the evaluation of hypothesis generation methods. Common hypothesis generation methods described are analytic studies (64.8%), descriptive epidemiology (33.7%), food or environmental sampling (32.8%) and facility inspections (27.9%). The least common methods included the use of a single interviewer (0.4%) and investigation of outliers (0.4%). Most studies reported using two or more methods to generate hypotheses (81.2%), with 29.2% of studies reporting using four or more. The use of multiple different hypothesis generation methods both within and between outbreaks highlights the complexity of enteric illness outbreak investigations. Future research should examine the effectiveness of each method and the contexts for which each is most effective in efficiently leading to source identification.
- Open Access
- 28 June 2019
- Published by Wiley in Zoonoses and Public Health
- Vol. 66 (7) , 739-758
Cache Valley virus: A scoping review of the global evidence
Cache Valley virus (CVV) is a mosquito‐borne RNA virus detected throughout North America, Central America and parts of South America. A limited number of human case reports have described severe illness. CVV infection has been associated with outbreaks of congenital defects in small ruminants in Canada and the United States. A scoping review was conducted to identify, characterize and summarize research on CVV, and to identify research gaps. A structured search was conducted in eight electronic databases, with additional search verification and grey literature investigation. All captured studies were independently appraised by two reviewers for relevance and data characterization. The review captured 143 relevant studies investigating CVV epidemiology (n = 104), pathogenesis (n = 37), viral characteristics (n = 24), transmission (n = 14), diagnostic test performance (n = 8) and mitigation strategies (n = 2). Evidence of CVV infection was found in mosquito studies (n = 47), and serological evidence of exposure was demonstrated in animals (n = 41), as well as human (n = 20) studies. In sheep, five outbreaks of birth defects following asymptomatic dam CVV infection during the first 50 days of pregnancy were reported. Only six human cases of CVV‐associated illness were captured, with case symptoms described as initially non‐specific, progressing to more severe clinical signs (e.g., meningitis). No research was identified investigating treatment, societal knowledge and risk perception, economic burden or predictive models related to the impact of climate change on CVV. CVV circulates in mosquito and animal species across a large area of the Americas. Small ruminants are the only animals in which CVV‐associated clinical disease has been extensively studied. It is likely that human cases are under‐reported or misdiagnosed. Future research should focus on the impact of CVV infection in human and animal populations.
- 28 June 2019
- Published by Wiley in Zoonoses and Public Health
- Vol. 66 (7) , 739-758
Open AccessCache Valley virus: A scoping review of the global evidence
Cache Valley virus (CVV) is a mosquito‐borne RNA virus detected throughout North America, Central America and parts of South America. A limited number of human case reports have described severe illness. CVV infection has been associated with outbreaks of congenital defects in small ruminants in Canada and the United States. A scoping review was conducted to identify, characterize and summarize research on CVV, and to identify research gaps. A structured search was conducted in eight electronic databases, with additional search verification and grey literature investigation. All captured studies were independently appraised by two reviewers for relevance and data characterization. The review captured 143 relevant studies investigating CVV epidemiology (n = 104), pathogenesis (n = 37), viral characteristics (n = 24), transmission (n = 14), diagnostic test performance (n = 8) and mitigation strategies (n = 2). Evidence of CVV infection was found in mosquito studies (n = 47), and serological evidence of exposure was demonstrated in animals (n = 41), as well as human (n = 20) studies. In sheep, five outbreaks of birth defects following asymptomatic dam CVV infection during the first 50 days of pregnancy were reported. Only six human cases of CVV‐associated illness were captured, with case symptoms described as initially non‐specific, progressing to more severe clinical signs (e.g., meningitis). No research was identified investigating treatment, societal knowledge and risk perception, economic burden or predictive models related to the impact of climate change on CVV. CVV circulates in mosquito and animal species across a large area of the Americas. Small ruminants are the only animals in which CVV‐associated clinical disease has been extensively studied. It is likely that human cases are under‐reported or misdiagnosed. Future research should focus on the impact of CVV infection in human and animal populations.
- Open Access
- 5 December 2018
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, 1-13
La Crosse virus: a scoping review of the global evidence
Urbanisation and climate change are altering the pattern of California serogroup viruses in North America. As La Crosse virus (LACV) is the most pathogenic of the California serogroup, it is important to identify changes in distribution, transmission and pathogenesis. A scoping review (ScR) was prioritised to summarise the global evidence on LACV. A comprehensive search strategy was used, identified references were screened for relevance and relevant articles were characterised. Each step was conducted by two independent reviewers using pre-tested forms. Analysis identified areas of research saturation and gaps. The ScR included 481 research articles that were mostly journal articles (78.2%) conducted in North America (90.9%) from 1969 to 2016. Most evidence focused on epidemiology (44.9%), virus characteristics (25.8%), transmission conditions (18.7%) and pathogenesis of LACV in hosts (18.3%). Fewer studies evaluated the accuracy of diagnostic tests (8.7%), the efficacy of treatments (3.5%), prevention and control strategies (3.1%), the economic burden of infection (0.6%) and social impact (0.2%) of LACV. None of the literature predicted the impact of climate change on LACV, nor were any cases reported in Canada. These findings are intended to guide research to close knowledge gaps and inform evidence-based decisions surrounding activities for the prevention and control of LACV.
- 5 December 2018
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, 1-13
Open AccessLa Crosse virus: a scoping review of the global evidence
Urbanisation and climate change are altering the pattern of California serogroup viruses in North America. As La Crosse virus (LACV) is the most pathogenic of the California serogroup, it is important to identify changes in distribution, transmission and pathogenesis. A scoping review (ScR) was prioritised to summarise the global evidence on LACV. A comprehensive search strategy was used, identified references were screened for relevance and relevant articles were characterised. Each step was conducted by two independent reviewers using pre-tested forms. Analysis identified areas of research saturation and gaps. The ScR included 481 research articles that were mostly journal articles (78.2%) conducted in North America (90.9%) from 1969 to 2016. Most evidence focused on epidemiology (44.9%), virus characteristics (25.8%), transmission conditions (18.7%) and pathogenesis of LACV in hosts (18.3%). Fewer studies evaluated the accuracy of diagnostic tests (8.7%), the efficacy of treatments (3.5%), prevention and control strategies (3.1%), the economic burden of infection (0.6%) and social impact (0.2%) of LACV. None of the literature predicted the impact of climate change on LACV, nor were any cases reported in Canada. These findings are intended to guide research to close knowledge gaps and inform evidence-based decisions surrounding activities for the prevention and control of LACV.
- Open Access
- 12 November 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0207067
A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn
Lyme disease (LD), caused by bacteria of the Borrelia burgdorferi sensu lato species complex, is the most common vector-borne disease in North America and Europe. A systematic review (SR) was conducted to summarize the global literature on adverse birth outcomes associated with gestational LD in humans. The SR followed an a priori protocol of pretested screening, risk of bias, and data extraction forms. Data were summarized descriptively and random effects meta-analysis (MA) was used where appropriate. The SR identified 45 relevant studies, 29 describing 59 cases reported as gestational LD in the United States, Europe, and Asia (1969–2017). Adverse birth outcomes included spontaneous miscarriage or fetal death (n = 12), newborn death (n = 8), and newborns with an abnormal outcome (e.g. hyperbilirubinemia, respiratory distress and syndactyly) at birth (n = 16). Only one report provided a full case description (clinical manifestations in the mother, negative outcome for the child, and laboratory detection of B. burgdorferi in the child) that provides some evidence for vertical transmission of B. burgdorferi that has negative consequences for the fetus. The results of 17 epidemiological studies are included in this SR. Prevalence of adverse birth outcomes in an exposed population (defined by the authors as: gestational LD, history of LD, tick bites or residence in an endemic area) was compared to that in an unexposed population in eight studies and no difference was reported. A meta-analysis of nine studies showed significantly fewer adverse birth outcomes in women reported to have been treated for gestational LD (11%, 95%CI 7–16) compared to those who were not treated during pregnancy (50%, 95%CI 30–70) providing indirect evidence of an association between gestational LD and adverse birth outcomes. Other risk factors investigated; trimester of exposure, length of LD during pregnancy, acute vs. disseminated LD at diagnosis, and symptomatic LD vs. seropositive women with no LD symptoms during pregnancy were not significantly associated with adverse birth outcomes. This SR summarizes evidence from case studies that provide some limited evidence for transplacental transmission of B. burgdorferi. There was inconsistent evidence for adverse birth outcomes of gestational LD in the epidemiological research, and uncommon adverse outcomes for the fetus may occur as a consequence of gestational LD. The global evidence does not fully characterize the potential impact of gestational LD, and future research that addresses the knowledge gaps may change the findings in this SR. Given the current evidence; prompt diagnosis and treatment of LD during pregnancy is recommended.
- 12 November 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0207067
Open AccessA systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn
Lyme disease (LD), caused by bacteria of the Borrelia burgdorferi sensu lato species complex, is the most common vector-borne disease in North America and Europe. A systematic review (SR) was conducted to summarize the global literature on adverse birth outcomes associated with gestational LD in humans. The SR followed an a priori protocol of pretested screening, risk of bias, and data extraction forms. Data were summarized descriptively and random effects meta-analysis (MA) was used where appropriate. The SR identified 45 relevant studies, 29 describing 59 cases reported as gestational LD in the United States, Europe, and Asia (1969–2017). Adverse birth outcomes included spontaneous miscarriage or fetal death (n = 12), newborn death (n = 8), and newborns with an abnormal outcome (e.g. hyperbilirubinemia, respiratory distress and syndactyly) at birth (n = 16). Only one report provided a full case description (clinical manifestations in the mother, negative outcome for the child, and laboratory detection of B. burgdorferi in the child) that provides some evidence for vertical transmission of B. burgdorferi that has negative consequences for the fetus. The results of 17 epidemiological studies are included in this SR. Prevalence of adverse birth outcomes in an exposed population (defined by the authors as: gestational LD, history of LD, tick bites or residence in an endemic area) was compared to that in an unexposed population in eight studies and no difference was reported. A meta-analysis of nine studies showed significantly fewer adverse birth outcomes in women reported to have been treated for gestational LD (11%, 95%CI 7–16) compared to those who were not treated during pregnancy (50%, 95%CI 30–70) providing indirect evidence of an association between gestational LD and adverse birth outcomes. Other risk factors investigated; trimester of exposure, length of LD during pregnancy, acute vs. disseminated LD at diagnosis, and symptomatic LD vs. seropositive women with no LD symptoms during pregnancy were not significantly associated with adverse birth outcomes. This SR summarizes evidence from case studies that provide some limited evidence for transplacental transmission of B. burgdorferi. There was inconsistent evidence for adverse birth outcomes of gestational LD in the epidemiological research, and uncommon adverse outcomes for the fetus may occur as a consequence of gestational LD. The global evidence does not fully characterize the potential impact of gestational LD, and future research that addresses the knowledge gaps may change the findings in this SR. Given the current evidence; prompt diagnosis and treatment of LD during pregnancy is recommended.